Editas Medicine Announces New Safety and Efficacy Data From the Edithal Trial of Reni-Cel in 7 Patients With Transfusion-Dependent Beta Thalassemia, Presented at the European Hematology Association (Eha) Annual Congress
editas medicine宣佈Edithal試驗對7名依賴輸血的β地中海貧血患者的Reni-Cel的新安全性和有效性數據，該數據在歐洲血液學學會（Eha）年會上發佈。